159 related articles for article (PubMed ID: 19486801)
1. VEGF and age-related macular degeneration.
McKay GJ; Silvestri G; Orr N; Chakravarthy U; Hughes AE
Ophthalmology; 2009 Jun; 116(6):1227.e1-3. PubMed ID: 19486801
[No Abstract] [Full Text] [Related]
2. A tag-single nucleotide polymorphisms approach to the vascular endothelial growth factor-A gene in age-related macular degeneration.
Richardson AJ; Islam FM; Guymer RH; Cain M; Baird PN
Mol Vis; 2007 Nov; 13():2148-52. PubMed ID: 18079689
[TBL] [Abstract][Full Text] [Related]
3. Combination therapy using the small interfering RNA bevasiranib.
Singerman L
Retina; 2009 Jun; 29(6 Suppl):S49-50. PubMed ID: 19553802
[TBL] [Abstract][Full Text] [Related]
4. Anti-Vascular Endothelial Growth Factor Injection for Exudative Age-related Macular Degeneration in Patients with Vitreo-Macular Traction.
Querques G
Am J Ophthalmol; 2009 Feb; 147(2):375-6; author reply 376-7. PubMed ID: 19166716
[No Abstract] [Full Text] [Related]
5. Combination therapy for age-related macular degeneration.
Patel S
Retina; 2009 Jun; 29(6 Suppl):S45-8. PubMed ID: 19553801
[TBL] [Abstract][Full Text] [Related]
6. Photodynamic therapy in the anti-VEGF era.
Fine HF
Br J Ophthalmol; 2007 Jun; 91(6):707-8. PubMed ID: 17510474
[TBL] [Abstract][Full Text] [Related]
7. Age-related macular degeneration.
Brucker AJ
Retina; 2009 Jun; 29(6 Suppl):S2-4. PubMed ID: 19553791
[TBL] [Abstract][Full Text] [Related]
8. Splicing factor polymorphisms, the control of VEGF isoforms and association with angiogenic eye disease.
Carter JG; Cherry J; Williams K; Turner S; Bates DO; Churchill AJ
Curr Eye Res; 2011 Apr; 36(4):328-35. PubMed ID: 21309690
[TBL] [Abstract][Full Text] [Related]
9. Strategies for inhibiting vascular endothelial growth factor.
Kaiser PK
Retina; 2009 Jun; 29(6 Suppl):S15-7. PubMed ID: 19553789
[TBL] [Abstract][Full Text] [Related]
10. Distribution of the C-460T polymorphism of the vascular endothelial growth factor gene in age-related macular degeneration.
Szaflik JP; Błasiak J; Krzyanowska A; Zaraś M; Janik-Papis K; Borucka AI; Woźniak K; Szaflik J
Klin Oczna; 2009; 111(4-6):125-7. PubMed ID: 19673440
[TBL] [Abstract][Full Text] [Related]
11. Rationale for combination therapy in age-related macular degeneration.
Spaide RF
Retina; 2009 Jun; 29(6 Suppl):S5-7. PubMed ID: 19553803
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk and antiangiogenic therapy for age-related macular degeneration.
Tuñón J; Ruiz-Moreno JM; Martín-Ventura JL; Blanco-Colio LM; Lorenzo O; Egido J
Surv Ophthalmol; 2009; 54(3):339-48. PubMed ID: 19422962
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting angiogenesis in retinoblastoma.
Apte RS; Harbour JW
Ophthalmic Res; 2007; 39(4):188-90. PubMed ID: 17556838
[No Abstract] [Full Text] [Related]
14. Association of age-related macular degeneration with polymorphisms in vascular endothelial growth factor and its receptor.
Galan A; Ferlin A; Caretti L; Buson G; Sato G; Frigo AC; Foresta C
Ophthalmology; 2010 Sep; 117(9):1769-74. PubMed ID: 20471686
[TBL] [Abstract][Full Text] [Related]
15. Pathology beyond neovascularization: new targets in age-related macular degeneration.
Heier JS
Retina; 2009 Jun; 29(6 Suppl):S39-41. PubMed ID: 19553799
[TBL] [Abstract][Full Text] [Related]
16. A 1-year retrospective review of ranibizumab for naive nonsubfoveal choroidal neovascularization secondary to age-related macular degeneration.
Arias L; Ruiz-Moreno JM; Gómez-Ulla F; Fernández M; Montero J
Retina; 2009; 29(10):1444-9. PubMed ID: 19730163
[TBL] [Abstract][Full Text] [Related]
17. Approaches toward combining photodynamic therapy with pharmaceuticals that alter vascular microenvironment.
Busch T
Retina; 2009 Jun; 29(6 Suppl):S36-8. PubMed ID: 19553798
[TBL] [Abstract][Full Text] [Related]
18. Opportunities and challenges in the development of combination therapy for the treatment of retinal diseases.
Hohman TC
Retina; 2009 Jun; 29(6 Suppl):S51-3. PubMed ID: 19553804
[TBL] [Abstract][Full Text] [Related]
19. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
[TBL] [Abstract][Full Text] [Related]
20. Combination angiostatic therapies: current status.
Peyman GA; Fiscella R; Conway M
Retina; 2009 Jun; 29(6 Suppl):S18-20. PubMed ID: 19553790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
